New Lilly cancer database tracks 'stepwise, continuous' progress
This article was originally published in Scrip
Executive Summary
Lilly has launched a new database for tracking the progress in cancer research and development aimed at informing public policy decisions about the value of therapies and efforts to accelerate biomedical innovation.